Ahmed Iqbal Ike K

Armstrong James J, De Francesco Ticiana, Beckers Henny J, Stalmans Ingeborg, Fea Antonio M, Sng Chelvin C A et al.

This study compared three primary glaucoma surgeries, finding SIBS microshunt achieved higher success and fewer complications than gelatin microstent or trabeculectomy, suggesting it's a superior option.

Muayad Jawad, Loya Asad, Hussain Zain S, Chauhan Muhammad Z, Alsoudi Amer F, De Francesco Ticiana et al.

GLP-1 agonists significantly lowered glaucoma risk (POAG, ocular hypertension, treatment need) compared to metformin in type 2 diabetics, suggesting potential ocular benefits beyond diabetes management.

De Francesco Ticiana, Mikula Eric, Lummis Wes, Sangalang Nathan, Ahmed Iqbal Ike K

This ex vivo study found standard gonioscopy, SLT, and laser iridotomy lenses significantly elevate IOP (around 20 mmHg), highlighting potential pressure spikes during these common procedures.

Ahmed Iqbal Ike K, Sheybani Arsham, De Francesco Ticiana, Samuelson Thomas W

This 5-year study found iStent inject comparable to phacoemulsification alone regarding corneal endothelial cell loss, whereas Hydrus and CyPass showed significantly greater loss, impacting long-term corneal health.

Bradley Chris, Ahmed Iqbal Ike K, Samuelson Thomas W, Chaglasian Michael, Barnebey Howard, Radcliffe Nathan et al.

This study found a virtual reality perimeter (Radius) is comparable to standard perimetry (HFA) for glaucoma staging, offering a clinically relevant alternative for assessing disease severity.

Xie Jim, Patil Nikhil S, Popovic Marko M, Kertes Peter J, Muni Rajeev H, Schlenker Matthew B et al.

This study found non-Hispanic Black race and poor health status are associated with self-reported glaucoma. Clinicians and policymakers should consider these social factors for risk assessment and public health interventions.

Kanjee Raageen, Popovic Marko M, Salimi Ali, Hutnik Cindy M L, Ahmed Iqbal Ike K, Saheb Hady

This study found prophylactic medications effectively reduce immediate post-cataract surgery IOP spikes, with intracameral cholinergics and FCCB formulations being most effective.

Samuelson Thomas W, De Francesco Ticiana, Ahmed Iqbal Ike K, Gedde Steven J, Paranjpe Vikram R, Singh Kuldev et al.

This case highlights managing severe progressive glaucoma after failed MIGS and medical therapy, where trabeculectomy achieved stability in one eye, emphasizing its role for advanced disease.

Dick H Burkhard, Mackert Marc J, Ahmed Iqbal Ike K, Denis Philippe, Hirneiß Christoph, Flowers Brian E et al.

This meta-analysis found the MINIject supraciliary implant safely and effectively lowered IOP and medication burden in POAG patients for two years, offering a bleb-free treatment option.

Schlenker Matthew B, Armstrong James J, De Francesco Ticiana, Ahmed Iqbal Ike K

This study found SIBS microshunt with MMC provides good 1-year glaucoma control and medication reduction, but success rates are lower in refractory eyes, combined procedures, and with insufficient MMC.

Montesano Giovanni, Ometto Giovanni, Ahmed Iqbal Ike K, Ramulu Pradeep Y, Chang David F, Crabb David P et al.

Nagy Zoltan Z, Kranitz Kinga, Ahmed Iqbal Ike K, De Francesco Ticiana, Mikula Eric, Juhasz Tibor

A pilot study of FLIGHT femtosecond laser trabeculotomy for glaucoma showed excellent safety and sustained IOP reduction (34.6% at 24 months) with patent channels, indicating a promising new treatment option.

Ahmed Iqbal Ike K, Sheybani Arsham, De Francesco Ticiana, Lass Jonathan H, Benetz Beth Ann, Samuelson Thomas W et al.

This 5-year study found iStent inject with phacoemulsification for glaucoma had no device-related complications or worse endothelial cell loss than phacoemulsification alone, demonstrating long-term corneal safety.

Montesano Giovanni, Ometto Giovanni, Ahmed Iqbal Ike K, Ramulu Pradeep Y, Chang David F, Crabb David P et al.

The HORIZON trial found that glaucoma patients receiving cataract surgery with a Hydrus microstent had significantly slower visual field progression over five years compared to cataract surgery alone.

Waldner Derek M, Chaban Yuri, Penny Michael D, Al-Ani Abdullah, Belkin Avner, Ahmed Iqbal Ike K et al.

This study found no significant difference in efficacy or safety between superior and inferior 180-degree GATT glaucoma surgery. Glaucoma type, advanced disease, and younger age increased failure risk.

Kryshtalskyj Michael T, Rai Amrit S, Durr Georges M, Ahmed Iqbal Ike K

This study validated the Iris GAP questionnaire, finding it reliably measures symptoms and appearance in patients with iris defects, distinguishing severity and showing improvement post-repair, making it a valuable clinical tool.

Ten Hulzen Richard D, Wagner Isabella V, Aref Ahmad A, Provencher Lorraine M, Razeghinejad Reza, Danesh-Meyer Helen V et al.

A misplanted glaucoma minishunt was found piercing the iris and capsular bag, embedding in the cataract. This "deadbolt" effect complicates cataract surgery and highlights the importance of precise shunt placement.

Ahmed Iqbal Ike K, De Francesco Ticiana, Rhee Douglas, McCabe Cathleen, Flowers Brian, Gazzard Gus et al.

The HORIZON trial found that adding a Schlemm's canal microstent to cataract surgery significantly improved long-term IOP control, reduced medication use, and lowered the need for further glaucoma surgery compared to cataract surgery alone.

Belkin Avner, Chaban Yuri Valere, Waldner Derek, Samet Saba, Ahmed Iqbal Ike K, Gooi Patrick et al.

GATT effectively treated uveitic glaucoma, achieving 71.8% success and significantly lowering IOP/medications without sight-threatening complications. This conjunctival-sparing procedure should be considered early.

Swan Russell J, Ferguson Tanner J, Shah Manjool, Muir Kelly W, Samuelson Thomas W, Ahmed Iqbal Ike K et al.

A multi-pressure dial applying negative pressure around the eye safely and effectively lowered intraocular pressure in a titratable manner, offering a novel non-pharmacologic glaucoma treatment strategy.

Ahmed Iqbal Ike K, Rhee Douglas J, Jones Jason, Singh Inder Paul, Radcliffe Nathan, Gazzard Gus et al.

The HORIZON study found Hydrus Microstent combined with cataract surgery safely reduced glaucoma medications and future surgery more effectively than cataract surgery alone for mild-to-moderate POAG.

Durr Georges M, Schlenker Matthew B, Samet Saba, Ahmed Iqbal Ike K

This study found the SIBS microshunt effectively lowered IOP in refractory glaucoma patients previously failing filtering surgery, showing reasonable one-year success with few complications, offering a viable treatment option.

Nichani Prem, Popovic Marko M, Schlenker Matthew B, Park Jeff, Ahmed Iqbal Ike K

This review of 3476 eyes found MIGS effectively lowers intraocular pressure and medication use, with favorable complication rates, particularly for iStent and Hydrus, supporting their role in glaucoma management.

Durr Georges M, Ahmed Iqbal Ike K

This review highlights rare but diverse IOL complications (decentration, UGH, opacification, refractive surprises). Proper identification and management are crucial for optimizing patient outcomes in modern cataract surgery.

Schlenker Matthew B, Durr Georges M, Michaelov Evan, Ahmed Iqbal Ike K

This study found a novel glaucoma microshunt with MMC achieved promising 1-year success rates (77-93%) with few complications, suggesting it's an effective new surgical option.